Benzinga | Dec 8, 2020 05:24AM EST

Gil Schwartzberg Reported Purchase of 210,528 Shares of Lixte Biotechnology Holdings, Inc. @ Avg Price of $4.75/ Share in Form 4 Filing on Monday